Integrated BioPharma (INBP) Insider Canarick Buys 50,000 Shares
Robert Canarick purchased 50,000 shares of INBP on June 24, 2026.
Reviewed by automated data checks against the source filing. How we make and check alerts
Robert Canarick bought 50,000 shares of Integrated BioPharma, Inc. ($INBP) on June 24, 2026. The trade was reported to the SEC in a Form 4 filing.
Since the trade, $INBP is up 0.0% after 1 week, down 11.1% after 1 month and up 0.0% to date (from the $0.18 close on Jun 24, 2026).
INBP
Integrated BioPharma, Inc.
Key Points
- Robert Canarick bought 50,000 shares of INBP on June 24, 2026, with shares trading at $0.18.
- Shares of INBP traded near $0.18 on Thursday, reflecting recent insider buying activity.
- Other insiders also bought 50,000 shares each on the same date, signaling interest in the stock.
Get $INBP trade alerts by text
We text you when insiders, Congress or big funds trade $INBP. Free.
Not investment advice. EarningsIQ is not a registered investment adviser, and this automated Integrated BioPharma, Inc. alert may contain errors. Disclosures
Robert Canarick made a move to increase his stake in INBP by purchasing 50,000 shares on June 24, 2026. The transaction took place without a specified purchase price, but shares of INBP traded around $0.18 on that Thursday.
Insider Buying and Selling at Integrated BioPharma, Inc.
In addition to Robert Canarick, several other insiders at INBP showed confidence in the company by buying shares on the same day. Desantis Damon, Friedman Eric, and Milmoe William each acquired 50,000 shares. These transactions were not part of any pre-planned trading programs. However, earlier in the year, on April 15, 2026, Milmoe William sold 11,201,964 shares, indicating a large divestment at that time.
Bottom Line
Insider buying often attracts investor attention as it can suggest confidence in the company's prospects. Robert Canarick's recent purchase of 50,000 shares of INBP adds to a series of similar buys by other insiders. While insider activity is one piece of the puzzle, it remains important to consider broader market conditions and company fundamentals when evaluating stock moves.
Related Filing Alerts
Source: Robert Canarick's Form 4 filing on $INBP (Jun 24, 2026). Find the original filing: INBP Form 4 filings on SEC EDGAR. Written by software, not financial advice. How we make alerts